메뉴 건너뛰기




Volumn 131, Issue 5, 2016, Pages 793-794

Commentary on “Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes”

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; HISTONE 1H3B K27M; HISTONE H3F3A; UNCLASSIFIED DRUG;

EID: 84962305144     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-016-1567-8     Document Type: Letter
Times cited : (6)

References (4)
  • 1
    • 84899570180 scopus 로고    scopus 로고
    • Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
    • COI: 1:CAS:528:DC%2BC2cXls1Khtbs%3D, PID: 24705254
    • Buczkowicz P, Hoeman C, Rakopoulos P et al (2014) Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 46:451–456. doi:10.1038/ng.2936
    • (2014) Nat Genet , vol.46 , pp. 451-456
    • Buczkowicz, P.1    Hoeman, C.2    Rakopoulos, P.3
  • 2
    • 84947617209 scopus 로고    scopus 로고
    • Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
    • COI: 1:CAS:528:DC%2BC2MXhsF2ru7%2FF, PID: 26399631
    • Castel D, Philippe C, Calmon R et al (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130:815–827. doi:10.1007/s00401-015-1478-0
    • (2015) Acta Neuropathol , vol.130 , pp. 815-827
    • Castel, D.1    Philippe, C.2    Calmon, R.3
  • 3
    • 84922503066 scopus 로고    scopus 로고
    • Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria
    • PID: 24903904
    • Jansen MH, Veldhuijzen van Zanten SE, Aliaga Sanchez et al (2015) Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol 17:160–166. doi:10.1093/neuonc/nou104
    • (2015) Neuro Oncol , vol.17 , pp. 160-166
    • Jansen, M.H.1    Veldhuijzen van Zanten, S.E.2    Aliaga, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.